ATLASInsmed (INSM) Q3 2026 earnings results
Insmed (INSM) reported EPS of -$0.46 against an analyst estimate of -$0.34: a miss of $0.12 (35.3%). The quarter ended Sep 30, 2026; the company reported on Thursday, October 29, 2026, before the open.
Status: Confirmed · cross-checked Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when Insmed reports
Track INSM free Add Insmed to a free ATLAS watchlist.
INSM Q3 2026 results at a glance
| EPS reported | -$0.46 |
|---|---|
| EPS estimate | -$0.34 |
| Surprise | Miss · -$0.12 (-35.3%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Oct 29, 2026, before the open |
| Status | Confirmed · cross-checked Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Insmed’s Q3 2026, a calendar-year company.
Insmed EPS surprise history: last 4 quarters
Insmed beat the EPS estimate in 2 of its last 4 reports, with an average surprise of +12.1%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | -$0.34 | -$0.46 | -35.3% | Miss | – |
| Aug 6, 2026 | -$0.68 | -$0.06 | +91.2% | Beat | +32.4% |
| May 7, 2026 | -$1.00 | -$0.76 | +24.0% | Beat | -26.1% |
| Feb 19, 2026 | -$1.17 | -$1.54 | -31.6% | Miss | +9.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
INSM stock reaction to the report
INSM moved +15.06% in the first session that reflects the report (close of Oct 28, 2026 $96.98 to close of Oct 29, 2026 $111.59). Since the report: +12.71% (latest close $109.31 on Nov 2, 2026, against $96.98 before the reaction).
Next INSM earnings report
Insmed has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the INSM earnings calendar.
ATLAS fair value and signal for INSM
| Last price | $109.31 (-2.9%) |
|---|---|
| Chance of a higher close in 1 month | 47% (normal range $97.51–$120.22) |
These are model outputs from the same valuation and calibrated model as the Insmed stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Insmed Q3 2026 earnings: frequently asked questions
Did Insmed beat earnings estimates for Q3 2026?
Insmed reported EPS of -$0.46 against an analyst estimate of -$0.34: a miss of $0.12 (35.3%).
When did Insmed report Q3 2026 results?
Insmed reported on Thursday, October 29, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does INSM beat EPS estimates?
In its last 4 reports with a recorded result, Insmed beat the EPS estimate 2 times; the average surprise was +12.1%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer